These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16000069)

  • 1. Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters.
    Wright A; Semyonov A; Dawes G; Crameri A; Lyons R; Stemmer WP; Apt D; Punnonen J
    Hum Gene Ther; 2005 Jul; 16(7):881-92. PubMed ID: 16000069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
    Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
    Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model.
    Suarez DL; Schultz-Cherry S
    Avian Dis; 2000; 44(4):861-8. PubMed ID: 11195640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
    Kachi S; Esumi N; Zack DJ; Campochiaro PA
    Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro search for alternative promoters to the human immediate early cytomegalovirus (IE-cMV) to express the G gene of viral haemorrhagic septicemia virus (VHSV) in fish epithelial cells.
    Ruiz S; Tafalla C; Cuesta A; Estepa A; Coll JM
    Vaccine; 2008 Dec; 26(51):6620-9. PubMed ID: 18840493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells.
    Byun HM; Suh D; Jeong Y; Wee HS; Kim JM; Kim WK; Ko JJ; Kim JS; Lee YB; Oh YK
    Biochem Biophys Res Commun; 2005 Jul; 332(2):518-23. PubMed ID: 15893736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
    Addison CL; Hitt M; Kunsken D; Graham FL
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
    Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
    Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
    Harms JS; Splitter GA
    Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
    Al-Dosari M; Zhang G; Knapp JE; Liu D
    Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution through DNA shuffling for the improvement and understanding of genes and promoters.
    Werkman JR; Pattanaik S; Yuan L
    Methods Mol Biol; 2011; 754():325-42. PubMed ID: 21720962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial antigen expression is an important component in inducing an immune response to orally administered Salmonella-delivered DNA vaccines.
    Gahan ME; Webster DE; Wesselingh SL; Strugnell RA; Yang J
    PLoS One; 2009 Jun; 4(6):e6062. PubMed ID: 19557169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of DNA vaccine immunogenicity by a dual antigen expression system.
    Sasaki S; Takeshita F; Oikawa T; Kojima Y; Xin KQ; Okuda K; Ishii N
    Biochem Biophys Res Commun; 2004 Feb; 315(1):38-43. PubMed ID: 15013422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.
    Qin L; Ding Y; Pahud DR; Chang E; Imperiale MJ; Bromberg JS
    Hum Gene Ther; 1997 Nov; 8(17):2019-29. PubMed ID: 9414251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.